India
-
News
Indians point to generics from Sanofi
Sanofi plans to divest Zentiva's generics business by the end of the year. The decision appeals to large Asian multinationals…
Leggi » -
News
Pharmaceuticals: only 3% of the 449 sites controlled by EU authorities in third countries were 'rejected', out of a total of 12,250. Ed
Rome, September 20. (AdnKronos Salute) – The rate of irregularities detected by the inspections of the European agencies at…
Leggi » -
News
Pharma India, the long road to regaining FDA trust. India is the largest generic producer
(Reuters Health) - Workers videotaped to ensure they follow standard procedures and 'fresh' training to the entire team if…
Leggi » -
News
Assogenerici: "Spc export exception, if 4 thousand more jobs arrive"
Rome, 22 May - Two billion euros: this is the value of the market that will originate from the patent expiries of…
Leggi » -
News
Drugs: WHO prequalifies generic active ingredient for new anti-hepatitis drugs
"Sofosbuvir - recalls the WHO - is an essential ingredient for new highly effective drugs against hepatitis C" by…
Leggi » -
First floor
EMA recommends the suspension of 342 generic medicines due to the unreliability of Indian bioequivalence studies. Ed
EMA Recommends Drug Suspension Due to Unreliable Studies from Micro Therapeutic Research Labs EMA – Press…
Leggi » -
News
Hepatitis C, Milanese pensioner wins legal battle: low-cost life-saving drugs from India
Medicines purchased online at one-thirtieth of the cost in Italy were stopped at customs and once released "for ...
Leggi » -
News
AIFA. Generic metformin cautionary recall made in India
Cautionary withdrawal of lots of METFORMIN MYLAN Generic tablets (various dosages) The Italian Medicines Agency (AIFA) announces that it has approved the withdrawal…
Leggi » -
News
Hepatitis C, yes of the judge to the life-saving drug bought abroad
The ordinance. The Court of Appeal of Rome agrees with a patient who had purchased the treatment in India THE RECIPE…
Leggi » -
News
EMA recommends suspension for medicines whose bioequivalence studies were conducted at the Semler Research Center site - Bangalore - India
The European Medicines Agency (EMA) has recommended the suspension in the EU of all [generic] medicines approved or in the process of…
Leggi »